SABBY MANAGEMENT, LLC - Q3 2023 holdings

$137 Million is the total value of SABBY MANAGEMENT, LLC's 84 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 75.3% .

 Value Shares↓ Weighting
SellISHARES TRput$58,483,266
-8.4%
3,309
-2.9%
42.80%
-18.0%
BuySPDR S&P 500put$43,602,960
+75.3%
1,020
+81.8%
31.91%
+56.8%
IWM NewISHARES TRetf$12,902,02073,000
+100.0%
9.44%
SPY NewSPDR S&P 500etf$2,564,8416,000
+100.0%
1.88%
SEEL NewSEELOS THERAPEUTICS INC$2,169,88611,792,861
+100.0%
1.59%
TC SellTUANCHE LTDads$951,400
-4.5%
1,829,616
-8.1%
0.70%
-14.6%
RCON SellRECON TECHNOLOGY LTDcl a$919,233
-15.3%
2,965,268
-6.0%
0.67%
-24.2%
SellBIORA THERAPEUTICS INC$817,129
-56.0%
376,557
-22.0%
0.60%
-60.7%
AKTX SellAKARI THERAPEUTICS PLCadr$703,459
-44.0%
178,091
-97.6%
0.52%
-49.9%
NewTONIX PHARMACEUTICALS HLDG$679,8681,247,465
+100.0%
0.50%
BuyREVIVA PHARMACEUTCLS HLDGS INCput$548,512
-1.1%
1,124
+18.8%
0.40%
-11.7%
SellREVIVA PHARMACEUTCLS HLDGS INCcall$536,312
-60.8%
1,099
-52.9%
0.39%
-64.8%
SellNISUN INTL ENT DVPMT GP CO LTD$528,145
-40.8%
220,981
-8.7%
0.39%
-47.0%
SellGLUCOTRACK INC$526,110
-25.0%
2,004,230
-1.4%
0.38%
-32.9%
DOGZ SellDOGNESS INTL CORPcl a$518,699
-39.2%
1,103,614
-5.6%
0.38%
-45.6%
BuyBIOLINERX LTDput$504,140
+190.2%
2,770
+154.4%
0.37%
+159.9%
NewFANGDD NETWORK GROUP LTDads$478,753621,757
+100.0%
0.35%
SellBRIACELL THERAPEUTICS CORPput$445,000
-18.3%
712
-16.0%
0.33%
-26.7%
APVO NewAPTEVO THERAPEUTICS INC$440,2761,334,169
+100.0%
0.32%
SellSOLIGENIX INC$412,864
-28.0%
740,564
-9.0%
0.30%
-35.6%
EZGO NewEZGO TECHNOLOGIES LTD$406,0372,847,387
+100.0%
0.30%
BLRX NewBIOLINERX LTDadr$382,200210,000
+100.0%
0.28%
NewCHECKPOINT THERAPEUTICS INC$348,920205,247
+100.0%
0.26%
NewREDHILL BIOPHARMA LTDads$323,853635,006
+100.0%
0.24%
SellPULMATRIX INC$307,241
-37.7%
151,350
-17.8%
0.22%
-44.3%
NewTOUGHBUILT INDUSTRIES INC$296,6531,521,296
+100.0%
0.22%
SellBIT BROTHER LTDcl a$290,707
-39.3%
567,343
-37.8%
0.21%
-45.7%
BuyREVELATION BIOSCIENCES INC$277,989
-16.3%
403,233
+14.2%
0.20%
-25.4%
NewALLARITY THERAPEUTICS INC$268,472359,400
+100.0%
0.20%
NewNEPTUNE WELLNESS SOLUTIONS INC$246,695186,890
+100.0%
0.18%
SellPHIO PHARMACEUTICALS CORP$235,619
-47.6%
156,039
-0.5%
0.17%
-53.3%
VRPX SellVIRPAX PHARMACEUTICALS INC$234,203
-45.8%
292,790
-26.8%
0.17%
-51.6%
BuyHARBOR CUSTOM DEVELOPMENT INC$231,968
-50.2%
164,516
+6.7%
0.17%
-55.4%
 GAMIDA CELL LTDput$231,132
-46.6%
2,2440.0%0.17%
-52.3%
BuyBIT DIGITAL INCput$223,416
+243.9%
1,044
+552.5%
0.16%
+209.4%
RVPH NewREVIVA PHARMACEUTCLS HLDGS INC$217,61444,593
+100.0%
0.16%
BuySCINAI IMMUNOTHERAPEUTICS LTDads$213,120
-20.8%
244,966
+28.3%
0.16%
-29.1%
PMCBD NewPHARMACYTE BIOTECH INC$203,96097,124
+100.0%
0.15%
SellMARPAI INC$197,690
-69.3%
299,077
-20.5%
0.14%
-72.4%
NewINVO BIOSCIENCE INC$182,554231,023
+100.0%
0.13%
BuyGEVO INCcall$142,443
+120.5%
1,197
+181.6%
0.10%
+96.2%
NCPL SellNETCAPITAL INC$136,956
-67.6%
334,039
-12.4%
0.10%
-71.1%
SellENSYSCE BIOSCIENCES INC$133,823
-76.9%
96,973
-69.9%
0.10%
-79.4%
BuyTRANSCODE THERAPEUTICS INC$125,830
-71.0%
250,309
+32.8%
0.09%
-74.1%
NewBRIGHT GREEN CORP$120,426304,183
+100.0%
0.09%
GMDA BuyGAMIDA CELL LTD$114,602
+0.7%
111,264
+88.8%
0.08%
-9.7%
SellARCADIA BIOSCIENCES INC$109,562
-76.1%
32,705
-72.3%
0.08%
-78.7%
New60 DEGREES PHARMACEUTICALS INC*w$107,351306,717
+100.0%
0.08%
AMPGW SellAMPLITECH GROUP INC*w$101,763
-42.1%
415,869
-2.0%
0.07%
-48.6%
NewMOBIQUITY TECHNOLOGIES$96,854144,000
+100.0%
0.07%
SellCINGULATE INC*w$93,352
-21.7%
565,769
-0.3%
0.07%
-30.6%
NewBLUEJAY DIAGNOSTICS INC$91,88721,221
+100.0%
0.07%
NRXP SellNRX PHARMACEUTICALS INC$84,500
-75.0%
325,000
-53.6%
0.06%
-77.6%
SellFORZA X1 INC$83,771
-85.5%
102,787
-73.9%
0.06%
-87.1%
SellBULLFROG AI HOLDINGS INC*w$82,223
-19.7%
145,090
-9.3%
0.06%
-28.6%
BuyTROIKA MEDIA GROUP INC$82,499
-32.2%
74,999
+37.4%
0.06%
-40.0%
 SPHERE 3D CORPcall$75,145
-31.4%
5650.0%0.06%
-38.9%
SellWEARABLE DEVICES LTD*w$70,753
-69.3%
672,553
-41.6%
0.05%
-72.3%
NewBRAINSTORM CELL THERAPEUTICScall$61,0103,049
+100.0%
0.04%
VINC SellVINCERX PHARMA INC$57,927
-56.8%
57,353
-44.4%
0.04%
-61.8%
BuyINFOBIRD CO LTDord$53,145
+80.6%
500,425
+1991.3%
0.04%
+62.5%
NewAPPLIED DNA SCIENCES INC$47,06938,900
+100.0%
0.03%
NewAPPLIED DNA SCIENCES INCput$47,069389
+100.0%
0.03%
NewSMART FOR LIFE INC$44,93454,492
+100.0%
0.03%
NewNOCERA INC$43,50528,528
+100.0%
0.03%
LEXXW SellLEXARIA BIOSCIENCE CORP*w$41,975
-20.6%
209,979
-12.6%
0.03%
-27.9%
 ESPORTS ENTMT GROUP INC*w$37,036
+21.2%
4,629,5290.0%0.03%
+8.0%
CTRM BuyCASTOR MARITIME INC$36,009
-2.1%
82,400
+0.6%
0.03%
-13.3%
 CASTOR MARITIME INCput$36,009
-2.7%
8240.0%0.03%
-13.3%
BCLI NewBRAINSTORM CELL THERAPEUTICS$27,310136,484
+100.0%
0.02%
 CANAAN INCcall$25,662
-14.6%
1410.0%0.02%
-24.0%
SellDOGNESS INTL CORPcall$25,098
-62.9%
534
-42.3%
0.02%
-67.3%
SellG MED INNOVATIONS HLDGS LTD$20,434
-92.2%
352,922
-48.9%
0.02%
-93.0%
Buy9 METERS BIOPHARMA INC$20,072
-97.1%
1,672,627
+61.1%
0.02%
-97.4%
NewGREENWAVE TECHNOLOGY SOLUTIONS$21,10131,036
+100.0%
0.02%
BuyBRUUSH ORAL CARE INC*w$19,246
-55.1%
551,458
+2.9%
0.01%
-60.0%
NewTINGO GROUP INCput$15,170148
+100.0%
0.01%
 INNOVATIVE EYEWEAR INC*w$13,454
-32.3%
104,5350.0%0.01%
-37.5%
OPTT  OCEAN POWER TECHNOLOGIES INC$10,373
-35.0%
26,5970.0%0.01%
-38.5%
NewMETA MATERIALS INCput$10,044474
+100.0%
0.01%
NewARQIT QUANTUM INCord$8,12113,648
+100.0%
0.01%
NewC3IS INC$4,68510,206
+100.0%
0.00%
 JEFFS BRANDS LTD*w$2,713
-50.5%
77,2820.0%0.00%
-50.0%
 BRAINSTORM CELL THERAPEUTICSput$2,121
-90.3%
1060.0%0.00%
-88.9%
ExitHARBOR CUSTOM DEVELOPMENT INC*w$0-753,522
-100.0%
-0.01%
ExitHEARTBEAM INC*w$0-17,908
-100.0%
-0.01%
ExitEFFECTOR THERAPEUTICS INCput$0-107
-100.0%
-0.01%
ExitBONE BIOLOGICS CORP$0-10,817
-100.0%
-0.01%
OG ExitONION GLOBAL LTDads$0-1,200,489
-100.0%
-0.02%
ExitT2 BIOSYSTEMS INC$0-448,900
-100.0%
-0.03%
ExitARCIMOTO INC$0-24,900
-100.0%
-0.03%
CNEY ExitCN ENERGY GROUP INCcl a$0-218,457
-100.0%
-0.04%
ExitGLOBUS MARITIME LTDput$0-529
-100.0%
-0.04%
ExitASCENT SOLAR TECHNOLOGIES INC$0-579,007
-100.0%
-0.06%
ExitBRIGHT GREEN CORPput$0-824
-100.0%
-0.07%
ExitCOSMOS HEALTH INC$0-35,006
-100.0%
-0.09%
ExitSPHERE 3D CORPput$0-843
-100.0%
-0.09%
ExitASSURE HOLDINGS CORP$0-132,610
-100.0%
-0.10%
ExitVERB TECHNOLOGY CO INC$0-129,900
-100.0%
-0.12%
ExitEDIBLE GARDEN AG INC$0-124,100
-100.0%
-0.13%
ExitIBIO INCput$0-2,974
-100.0%
-0.15%
ExitSMART FOR LIFE INC$0-249,385
-100.0%
-0.16%
ExitOCEANPAL INC$0-118,854
-100.0%
-0.16%
ExitKIORA PHARMACEUTICALS INC$0-312,369
-100.0%
-0.16%
ExitNEPTUNE WELLNESS SOLUTIONS INC$0-1,615,607
-100.0%
-0.19%
ExitIMPERIAL PETE INCput$0-795
-100.0%
-0.20%
MOBQ ExitMOBIQUITY TECHNOLOGIES INC$0-2,167,280
-100.0%
-0.20%
ExitADITXT INC$0-589,560
-100.0%
-0.22%
ExitBRIDGEBIO PHARMA INCcall$0-194
-100.0%
-0.27%
RWLK ExitREWALK ROBOTICS LTD$0-567,394
-100.0%
-0.28%
GLBS ExitGLOBUS MARITIME LTD$0-411,907
-100.0%
-0.30%
ExitHILLSTREAM BIOPHARMA INC$0-1,325,219
-100.0%
-0.40%
ExitPANBELA THERAPEUTICS INC$0-235,819
-100.0%
-0.44%
JUPW ExitJUPITER WELLNESS INC$0-1,421,797
-100.0%
-0.49%
ExitAVENUE THERAPEUTICS INC$0-553,338
-100.0%
-0.53%
ExitSHF HOLDINGS INCcl a$0-1,262,779
-100.0%
-0.55%
ExitITERUM THERAPEUTICS PLC$0-75,000
-100.0%
-0.92%
ExitSIDUS SPACE INCcl a$0-6,413,644
-100.0%
-0.95%
ExitSONNET BIOTHERAPEUTICS HLDNG INC$0-3,291,060
-100.0%
-1.32%
ExitBRAINSTORM CELL THERAPEUTICS$0-1,267,871
-100.0%
-2.14%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SPDR S&P 500 ETF TRUST UNIT37Q3 202349.1%
ISHARES TR35Q3 202352.2%
SPDR S&P BIOTECHNOLOGY32Q3 202212.8%
AMARIN CORP PLC30Q4 20212.0%
BIOGEN INC24Q1 202126.2%
SAREPTA THERAPEUTICS INC24Q3 20204.6%
BIOGEN INC23Q1 202113.7%
SAREPTA THERAPEUTICS INC22Q3 20206.2%
BRAINSTORM CELL THERAPEUTICS INC21Q3 20231.6%
VERTEX PHARMACEUTICALS INC20Q1 201812.6%

View SABBY MANAGEMENT, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
SABBY MANAGEMENT, LLC Q3 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
AGM GROUP HOLDINGS, INC.January 10, 2023627,9362.6%
Bit Digital, IncJanuary 10, 20233,166,9173.8%
Cingulate Inc.January 10, 2023105.0%
Context Therapeutics Inc.January 10, 2023796,7065.0%
HeartBeam, Inc.January 10, 2023271,7883.4%
PharmaCyte Biotech, Inc.January 10, 2023934,4565.0%
Rebus Holdings, Inc.Sold outJanuary 10, 202300.0%
TANTECH HOLDINGS LTDJanuary 10, 202341,5000.6%
Quanergy Systems, Inc.January 04, 2023936,9055.8%
TuanChe LtdJanuary 04, 20232,384,71310.0%

View SABBY MANAGEMENT, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G2024-01-04
SC 13G2024-01-04
SC 13G2024-01-04
SC 13G2024-01-04
SC 13G2024-01-04
SC 13G2024-01-03
SC 13G2024-01-03
SC 13G2024-01-03
SC 13G2024-01-03

View SABBY MANAGEMENT, LLC's complete filings history.

Compare quarters

Export SABBY MANAGEMENT, LLC's holdings